Phibro Animal Health Corporation (PAHC)
USD 17.45
(-1.52%)
USD 17.45
(-1.52%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 454.84 Million USD | -2.95% |
| 2023 | 468.68 Million USD | 18.28% |
| 2022 | 396.23 Million USD | 5.24% |
| 2021 | 376.49 Million USD | 0.56% |
| 2020 | 374.37 Million USD | 39.38% |
| 2019 | 268.6 Million USD | -5.16% |
| 2018 | 283.21 Million USD | 10.17% |
| 2017 | 257.05 Million USD | -19.44% |
| 2016 | 319.1 Million USD | 22.59% |
| 2015 | 260.3 Million USD | -6.22% |
| 2014 | 277.57 Million USD | -17.94% |
| 2013 | 338.23 Million USD | 14.18% |
| 2012 | 296.22 Million USD | 0.0% |
| 2007 | 228.6 Million USD | 9.06% |
| 2006 | 209.6 Million USD | 22.07% |
| 2005 | 171.7 Million USD | 4.5% |
| 2004 | 164.3 Million USD | 25.71% |
| 2003 | 130.7 Million USD | -27.19% |
| 2002 | 179.5 Million USD | 14.04% |
| 2001 | 157.4 Million USD | 6.28% |
| 2000 | 148.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 480.12 Million USD | 1.04% |
| 2024 FY | 454.84 Million USD | -2.95% |
| 2024 Q3 | 472.76 Million USD | -1.53% |
| 2024 Q4 | 454.84 Million USD | -3.79% |
| 2024 Q1 | 475.18 Million USD | 1.39% |
| 2023 Q3 | 480.47 Million USD | 8.38% |
| 2023 Q1 | 426.83 Million USD | 7.72% |
| 2023 FY | 468.68 Million USD | 18.28% |
| 2023 Q4 | 468.68 Million USD | -2.45% |
| 2023 Q2 | 443.32 Million USD | 3.86% |
| 2022 FY | 396.23 Million USD | 5.24% |
| 2022 Q3 | 384.93 Million USD | 3.66% |
| 2022 Q4 | 396.23 Million USD | 2.94% |
| 2022 Q1 | 397.64 Million USD | 5.62% |
| 2022 Q2 | 371.35 Million USD | -6.61% |
| 2021 Q3 | 364.48 Million USD | -3.18% |
| 2021 Q4 | 376.49 Million USD | 3.3% |
| 2021 Q2 | 376.43 Million USD | -3.55% |
| 2021 FY | 376.49 Million USD | 0.56% |
| 2021 Q1 | 390.28 Million USD | 4.25% |
| 2020 FY | 374.37 Million USD | 39.38% |
| 2020 Q1 | 362.04 Million USD | 34.79% |
| 2020 Q3 | 363.06 Million USD | -2.14% |
| 2020 Q4 | 374.37 Million USD | 3.12% |
| 2020 Q2 | 371.01 Million USD | 2.48% |
| 2019 Q2 | 292.94 Million USD | -1.85% |
| 2019 Q3 | 293.35 Million USD | 0.14% |
| 2019 Q4 | 268.6 Million USD | -8.44% |
| 2019 FY | 268.6 Million USD | -5.16% |
| 2019 Q1 | 298.47 Million USD | 5.39% |
| 2018 Q1 | 269.75 Million USD | 4.94% |
| 2018 Q3 | 278.82 Million USD | 0.96% |
| 2018 Q4 | 283.21 Million USD | 1.57% |
| 2018 FY | 283.21 Million USD | 10.17% |
| 2018 Q2 | 276.18 Million USD | 2.38% |
| 2017 Q3 | 260.15 Million USD | -10.08% |
| 2017 Q4 | 257.05 Million USD | -1.19% |
| 2017 FY | 257.05 Million USD | -19.44% |
| 2017 Q1 | 305.18 Million USD | -4.36% |
| 2017 Q2 | 289.31 Million USD | -5.2% |
| 2016 Q4 | 319.1 Million USD | -4.51% |
| 2016 Q3 | 334.19 Million USD | 19.46% |
| 2016 Q1 | 274.5 Million USD | 5.46% |
| 2016 Q2 | 279.74 Million USD | 1.91% |
| 2016 FY | 319.1 Million USD | 22.59% |
| 2015 Q3 | 266.41 Million USD | -0.31% |
| 2015 FY | 260.3 Million USD | -6.22% |
| 2015 Q4 | 260.3 Million USD | -2.3% |
| 2015 Q2 | 267.25 Million USD | -0.62% |
| 2015 Q1 | 268.91 Million USD | -3.12% |
| 2014 Q4 | 277.57 Million USD | -23.64% |
| 2014 Q1 | 407.06 Million USD | 20.35% |
| 2014 FY | 277.57 Million USD | -17.94% |
| 2014 Q2 | 333.34 Million USD | -18.11% |
| 2014 Q3 | 363.48 Million USD | 9.04% |
| 2013 Q4 | 338.23 Million USD | 0.0% |
| 2013 FY | 338.23 Million USD | 14.18% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 296.22 Million USD | 0.0% |
| 2007 FY | 228.6 Million USD | 9.06% |
| 2006 Q3 | 166.9 Million USD | -1.3% |
| 2006 FY | 209.6 Million USD | 22.07% |
| 2006 Q1 | 170.9 Million USD | -0.47% |
| 2006 Q2 | 169.1 Million USD | -1.05% |
| 2005 Q2 | 170.5 Million USD | 3.9% |
| 2005 Q1 | 164.1 Million USD | -0.12% |
| 2005 FY | 171.7 Million USD | 4.5% |
| 2005 Q4 | 171.7 Million USD | -2.44% |
| 2005 Q3 | 176 Million USD | 3.23% |
| 2004 Q1 | 117.2 Million USD | -10.33% |
| 2004 Q4 | 164.3 Million USD | -1.26% |
| 2004 Q3 | 166.4 Million USD | 3.55% |
| 2004 FY | 164.3 Million USD | 25.71% |
| 2004 Q2 | 160.7 Million USD | 37.12% |
| 2003 Q2 | 155.2 Million USD | -2.02% |
| 2003 Q1 | 158.4 Million USD | 0.0% |
| 2003 FY | 130.7 Million USD | -27.19% |
| 2003 Q4 | 130.7 Million USD | -0.15% |
| 2003 Q3 | 130.9 Million USD | -15.66% |
| 2002 FY | 179.5 Million USD | 14.04% |
| 2001 FY | 157.4 Million USD | 6.28% |
| 2000 FY | 148.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -24596.751% |
| Alpha Teknova, Inc. | 1.97 Million USD | -22941.844% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | -382.816% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | -506.866% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | -4.482% |
| Cosmos Health Inc. | 8.59 Million USD | -5194.597% |
| Journey Medical Corporation | -9.7 Million USD | 4784.787% |
| Embecta Corp. | 1.31 Billion USD | 65.332% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 0.84% |
| Dynavax Technologies Corporation | 106.63 Million USD | -326.545% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 447.665% |
| Pacira BioSciences, Inc. | 432.74 Million USD | -5.107% |
| PainReform Ltd. | -7.95 Million USD | 5821.333% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 3009.219% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 3009.219% |
| SCYNEXIS, Inc. | -19.35 Million USD | 2450.625% |
| Safety Shot Inc | -2.28 Million USD | 20011.179% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 4923.53% |
| Procaps Group, S.A. | 242.93 Million USD | -87.232% |
| Theratechnologies Inc. | 24.87 Million USD | -1728.821% |
| Harrow Health, Inc. | 116.41 Million USD | -290.704% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 18149.444% |
| Biofrontera Inc. | 4.05 Million USD | -11114.152% |
| DURECT Corporation | -7.65 Million USD | 6042.592% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 1456.656% |
| Cronos Group Inc. | -663.32 Million USD | 168.57% |
| OptiNose, Inc. | 58.06 Million USD | -683.339% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 27.036% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 3221.37% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 8870.599% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -2929.681% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 7252.065% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -425550.623% |
| Radius Health, Inc. | 359.28 Million USD | -26.599% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -230541.603% |
| ProPhase Labs, Inc. | 19.23 Million USD | -2265.171% |
| Procaps Group S.A. | 242.93 Million USD | -87.232% |
| Alvotech | 1.06 Billion USD | 57.264% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -12266.667% |
| Viatris Inc. | 17.13 Billion USD | 97.345% |
| Rockwell Medical, Inc. | 4.45 Million USD | -10107.495% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 9426.348% |
| SIGA Technologies, Inc. | -148.68 Million USD | 405.919% |
| Tilray Brands, Inc. | 158.97 Million USD | -186.108% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | -273.137% |
| Shineco, Inc. | 29.29 Million USD | -1452.889% |
| PetIQ, Inc. | 351.93 Million USD | -29.242% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 15776.625% |
| Incannex Healthcare Limited | -5.48 Million USD | 8392.543% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | -156.54% |
| Alimera Sciences, Inc. | 55.3 Million USD | -722.372% |
| Silver Spike Investment Corp. | -32.61 Million USD | 1494.735% |
| Assertio Holdings, Inc. | -32.52 Million USD | 1498.278% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 30652.783% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 9088.369% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 9548.4% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 5637.801% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -10686.009% |
| Hempacco Co., Inc. | 13.61 Million USD | -3240.85% |
| Talphera, Inc. | -5.72 Million USD | 8050.463% |
| Alvotech | 1.06 Billion USD | 57.264% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -6265.934% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 570.32% |
| Currenc Group, Inc. | -16.57 Million USD | 2844.479% |
| Kamada Ltd. | -46.43 Million USD | 1079.606% |
| Indivior PLC | -33.95 Million USD | 1439.674% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -174455.404% |
| Flora Growth Corp. | -713 Thousand USD | 63893.268% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 5637.801% |
| Evolus, Inc. | 63.7 Million USD | -613.954% |
| HUTCHMED (China) Limited | -197.45 Million USD | 330.351% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 5.065% |
| Akanda Corp. | 3.9 Million USD | -11548.035% |